The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for American Type Culture Collection sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
American Type Culture Collection (ATCC) is a biological materials and information resource and standards organization. The company offers microbe products and cell products such as animal cells, hTERT immortalized cells and human cells. Its services include cell authentication, cell bank production, depositing with ATCC and cGMP mammalian cell banking and biorepository. The company collaborates with from large pharmaceutical and diagnostic companies to biotech startups including companies developing in vivo and in vitro research models, molecular diagnostic companies, regulatory agencies, vaccine manufacturers, universities and other nonprofits. ATCC is headquartered in Manassas, Virginia, the US.
The key metrics of American Type Culture Collection related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As American Type Culture Collection is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as American Type Culture Collection.
For a detailed understanding of the performance of American Type Culture Collection, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.